Prothena Corporation plc
USD9.97
-0.05 (-0.50%)
CEO
Gene Kinney
IPO Date
2012-12-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IE
Open
$10.05
Prev. Close
$10.02
Day Low
$9.78
Day High
$10.11
52W Low
$5.96
52W High
$11.80
Market Cap
$0.52B
Volume
0.41M
| -6.1 |
| 31 Dec 2023 | FY | 100.0% | -160.9% | -26.2% | -21.1% | 0.02 | 11.24 | -13.2 |
| 31 Dec 2022 | FY | 100.0% | -217.0% | -18.8% | -15.4% | 0.01 | 14.34 | -24.4 |
| 31 Dec 2021 | FY | 100.0% | 33.4% | 14.4% | 11.0% | 0.03 | 17.48 | 32.6 |
| 31 Dec 2020 | FY | -8678.9% | -13029.8% | -60.4% | -33.4% | 0.10 | 11.58 | -4.3 |
| 31 Dec 2019 | FY | -6145.2% | -9542.6% | -28.5% | -18.5% | 0.08 | 21.36 | -8.1 |
| 31 Dec 2018 | FY | -10495.1% | -16297.9% | -48.2% | -31.2% | 0.16 | 28.90 | -2.6 |
| 31 Dec 2017 | FY | -388.9% | -556.8% | -37.6% | -30.9% | 0.13 | 11.41 | -9.2 |
| 31 Dec 2016 | FY | -11230.2% | -15176.1% | -43.8% | -34.8% | 0.14 | 9.53 | -10.6 |
| -6.0 |
| 30 Sept 2025 | Q3 | -1098.3% | -1513.1% | -12.4% | -10.4% | 0.03 | 6.61 | -3.6 |
| 30 Jun 2025 | Q2 | 100.0% | -2845.4% | -38.8% | -31.5% | 0.03 | 5.68 | -0.6 |
| 31 Mar 2025 | Q1 | 100.0% | -2128.5% | -13.8% | -12.2% | 0.02 | 9.00 | -2.8 |
| 31 Dec 2024 | Q4 | 100.0% | -2729.9% | -11.9% | -10.6% | 0.02 | 10.01 | -3.2 |
| 30 Sept 2024 | Q3 | 100.0% | -6082.6% | -11.0% | -9.9% | 0.02 | 11.52 | -3.8 |
| 30 Jun 2024 | Q2 | 100.0% | 50.7% | 11.5% | 10.4% | 0.02 | 12.54 | 4.1 |
| 31 Mar 2024 | Q1 | 100.0% | -144478.0% | -14.4% | -11.6% | 0.02 | 13.08 | -4.9 |
| 31 Dec 2023 | Q4 | -19485.8% | -21353.2% | -12.0% | -9.7% | 0.02 | 11.24 | -7.2 |